However, mitochondrial function seems neither affected in the NASH livers, nor by MSC treatment, as may be deduced from the unchanged expression of the mitochondrial proteins ACSL1 and ACAA2. This evidence concerns the gene ACSL1 and metabolic dysfunction-associated steatohepatitis.